Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

A Phase 3 Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety
Comparison of Fixed-Dose Ranges (mg/kg/day) of Tomoxetine with Placebo in Child and Adolescent Outpatients with ADHD, Aged 8 to 18 Years
Atomoxetine
B4Z-MC-LYAC
Not available
Attention Deficit Hyperactivity Disorder
Phase 3
 
A link to Clinicaltrials.gov and a NCT ID number are not available for this study because the study was conducted before regulatory requirements to register studies.
November 2014

Powered by ideaPoint, Inc.